PUBLISHER: Mordor Intelligence | PRODUCT CODE: 1687698
PUBLISHER: Mordor Intelligence | PRODUCT CODE: 1687698
The Dental Implants Market size is estimated at USD 5.33 billion in 2025, and is expected to reach USD 7.75 billion by 2030, at a CAGR of 7.8% during the forecast period (2025-2030).
The increasing burden of dental diseases, the rising geriatric population, the increasing demand for cosmetic dentistry, and increasing strategic activities by key players are expected to drive market growth.
The increasing burden of dental diseases is expected to drive the market. For instance, according to the NHS (National Health Service) Dental Statistics for England annual report published in August 2023, around 18.1 million and 6.4 million adults and children, respectively, visited NHS dentists in 2022. Furthermore, around 32.5 million courses of dental treatment were delivered in 2022. Hence, this significant rise in dental cases is expected to drive the market during the forecast period.
According to the article published in the Journal of Personalized Medicine in March 2022, the geriatric population is more prone to dental diseases. Hence, the rising geriatric population is expected to drive the market. For instance, as per the World Social Report published in January 2023, between 2021 and 2050, the number of adults 65 and older is expected to increase from 761 million to 1.6 billion. Hence, the rising geriatric population, which is more prone to dental diseases, is expected to increase the demand for dental implants, driving market growth.
Strategic activities and product launches by key players are also expected to drive market growth. For instance, in May 2023, Henry Schein Inc. acquired Brazilian implant manufacturer SIN Implant Systems. With this acquisition, SIN became part of Henry Schein's Global Oral Reconstruction Group, a collective of businesses and companies forming a global dental implant supplier.
Thus, factors such as the rising burden of dental diseases, the increasing geriatric population, and the increasing adoption of strategic activities, such as acquisitions and product launches, by companies are anticipated to drive the market over the forecast period. However, reimbursement issues, the high cost of dental implants, and the lack of awareness are expected to hinder market growth over the forecast period.
Titanium dental implants are typically used to replace damaged or missing teeth. Titanium dental implants are the most commonly used implants because of their durability and functionality. Factors such as the increasing prevalence of tooth loss cases, biocompatibility, and low-cost advantages over other implants of titanium implants and new product launches are expected to drive segmental growth over the forecast period.
Titanium is used in alloys to fabricate dental implants due to its good mechanical properties, low density, and good bone-contact biocompatibility. For instance, a study published by the National Library of Medicine in April 2022 stated that titanium implants were more commonly used dental implants than other types of implants due to their high biocompatibility and low cost compared to other implants. In addition, according to an NCBI research study published in May 2022, titanium is a bioinert material, inducing little or no deleterious effect on the surrounding tissue, making it the preferred choice for dental implants. Hence, good mechanical properties and cost-effectiveness of titanium dental implants are expected to propel segmental revenue.
The increasing product launches and strategic activities by key players are expected to drive segmental growth over the forecast period. In November 2022, ZimVie launched the TSX Implant (titanium implant) in the United States, the latest innovation in the company's surgical, restorative, and digital dentistry solutions platform. Hence, strategic activities and product launches are expected to drive the segment's growth.
Therefore, the above-mentioned factors, such as biocompatibility, low-cost advantages of titanium implants over other implants, and new product launches, are anticipated to drive segmental growth over the forecast period.
North America is expected to hold a significant share of the market over the forecast period owing to factors such as the increasing prevalence of dental diseases, wide acceptance of technological advancements in dental implants, and an increasing number of dental visits propelling the market's growth. According to the study published in the Journal of the American Dental Association in April 2022, the prevalence of untreated caries was 21.3% in 2020. The prevalence of coronal and root caries was 17.9% and 10.1%, respectively, in 2020. Such a high number of dental diseases may increase the demand for dental implants, propelling the market's growth in the region over the forecast period.
Increasing strategic activities, such as product launches and acquisitions, by key players are also expected to drive the market during the forecast period. For instance, in November 2023, Keystone Dental Holdings launched the GENESIS ACTIVE Implant System, a complete restorative portfolio of dental implant solutions. GENESIS ACTIVE implants are coated with a BioSpark surface treatment designed to mimic natural bone and promote rapid osseointegration. In December 2022, ProSmile launched its SmartArches Dental Implants (SmartArches) in the United States. SmartArches locations are specialty dental offices offering patients various affordable and reliable dental implant services, including implants and full mouth reconstruction.
Therefore, the aforementioned factors, such as the increasing prevalence of dental diseases and new product launches, are expected to drive the market in North America.
The dental implants market is moderately competitive and dominated by major players. Companies are implementing certain strategic initiatives, such as mergers, new product launches, acquisitions, and partnerships, which help them strengthen their market positions. Some of the key players are Institut Straumann AG, Dentsply Sirona, Zimmer Biomet, Osstem Implant Co. Ltd, DentiumUSA, Danaher Corporation (Nobel Biocare Services AG), and Thommen Medical AG.